{"transactions":[{"id":731799,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2026-06-18T21:00:11.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":39453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares (\"ADSs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest in equal monthly installments over the 12 months following June 17, 2026, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2027 annual shareholder meeting,"},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":39453,"derivative":{"exercise_price":15,"expiration_date":"2036-06-16","underlying":"Ordinary Shares","underlying_shares":39453},"source":{"system":"sec-edgar","filing":"0001202785-26-000004","document":"form4-06182026_050606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202785/000120278526000004/form4-06182026_050606.xml","form_type":"4"}},{"id":740077,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-13T00:00:10.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal monthly installments over the 12 months following June 11, 2026, provided that the shares subject to the option will in any case be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on each such date."}],"balance_after":15500,"derivative":{"exercise_price":13.66,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":15500},"source":{"system":"sec-edgar","filing":"0001202785-26-000002","document":"form4-06122026_080605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817713/000120278526000002/form4-06122026_080605.xml","form_type":"4"}},{"id":740076,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-13T00:00:10.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of (i) June 11, 2027 and (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continuous service on such date."}],"balance_after":15481,"source":{"system":"sec-edgar","filing":"0001202785-26-000002","document":"form4-06122026_080605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817713/000120278526000002/form4-06122026_080605.xml","form_type":"4"}},{"id":741769,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:42:00.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":34843,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase shares of the Issuer's common stock, which vests in full on the earlier of (i) June 9, 2027 or (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":34843,"derivative":{"exercise_price":15.22,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":34843},"source":{"system":"sec-edgar","filing":"0001193125-26-267739","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000119312526267739/ownership.xml","form_type":"4"}},{"id":1101595,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-06-25T21:45:09.000Z","date":"2025-06-23","kind":"grant","planned":false,"acquired":true,"shares":51804,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares (\"ADSs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest in equal monthly installments over the 12 months following June 23, 2025, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2026 annual shareholder meeting,"},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":51804,"derivative":{"exercise_price":7.37,"expiration_date":"2035-06-22","underlying":"Ordinary Shares","underlying_shares":51804},"source":{"system":"sec-edgar","filing":"0001415889-25-018215","document":"form4-06252025_050605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202785/000141588925018215/form4-06252025_050605.xml","form_type":"4"}},{"id":1111876,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-13T23:30:18.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":11667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal monthly installments over the 12 months following June 11, 2025, provided that the shares subject to the option will in any case be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on each such date."}],"balance_after":11667,"derivative":{"exercise_price":25.46,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":11667},"source":{"system":"sec-edgar","filing":"0001415889-25-017315","document":"form4-06132025_070611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817713/000141588925017315/form4-06132025_070611.xml","form_type":"4"}},{"id":1111875,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T23:30:18.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of (i) June 11, 2026 and (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continuous service on such date."}],"balance_after":9981,"source":{"system":"sec-edgar","filing":"0001415889-25-017315","document":"form4-06132025_070611.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817713/000141588925017315/form4-06132025_070611.xml","form_type":"4"}},{"id":1162508,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-01T22:00:21.000Z","date":"2025-04-29","kind":"grant","planned":false,"acquired":true,"shares":23017,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase 23,017 shares of the Issuer's common stock, which vests in full on the earlier of (i) April 29, 2026 or (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the recipient's continued service to the Issuer."}],"balance_after":23017,"derivative":{"exercise_price":10.14,"expiration_date":"2035-04-29","underlying":"Common Stock","underlying_shares":23017},"source":{"system":"sec-edgar","filing":"0000950170-25-062091","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000095017025062091/ownership.xml","form_type":"4"}},{"id":1449407,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-25T00:00:08.000Z","date":"2024-07-19","kind":"grant","planned":false,"acquired":true,"shares":4111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in twelve equal monthly installments over one year, subject to the Reporting Person's continuous service on each such date."}],"balance_after":4111,"derivative":{"exercise_price":44.68,"expiration_date":"2034-07-18","underlying":"Common Stock","underlying_shares":4111},"source":{"system":"sec-edgar","filing":"0001415889-24-020057","document":"form4a-07242024_080704.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817713/000141588924020057/form4a-07242024_080704.xml","form_type":"4/A","original_submission_date":"2024-07-22"}},{"id":1449406,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-25T00:00:08.000Z","date":"2024-07-19","kind":"grant","planned":false,"acquired":true,"shares":1231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on July 19, 2025, subject to the Reporting Person's continuous service on such date."}],"balance_after":6231,"source":{"system":"sec-edgar","filing":"0001415889-24-020057","document":"form4a-07242024_080704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817713/000141588924020057/form4a-07242024_080704.xml","form_type":"4/A","original_submission_date":"2024-07-22"}},{"id":1450526,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-23T00:04:42.000Z","date":"2024-07-19","kind":"grant","planned":false,"acquired":true,"shares":8350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option will vest in twelve equal monthly installments over one year, subject to the Reporting Person's continuous service on each such date."}],"balance_after":8350,"derivative":{"exercise_price":44.68,"expiration_date":"2034-07-18","underlying":"Common Stock","underlying_shares":8350},"source":{"system":"sec-edgar","filing":"0001415889-24-019904","document":"form4-07232024_120738.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1817713/000141588924019904/form4-07232024_120738.xml","form_type":"4"}},{"id":1450525,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-23T00:04:42.000Z","date":"2024-07-19","kind":"grant","planned":false,"acquired":true,"shares":16700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option will vest in thirty-six equal monthly installments over three years, subject to the Reporting Person's continuous service on each such date."}],"balance_after":16700,"derivative":{"exercise_price":44.68,"expiration_date":"2034-07-18","underlying":"Common Stock","underlying_shares":16700},"source":{"system":"sec-edgar","filing":"0001415889-24-019904","document":"form4-07232024_120738.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1817713/000141588924019904/form4-07232024_120738.xml","form_type":"4"}},{"id":1450524,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-23T00:04:42.000Z","date":"2024-07-19","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the grant of RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on July 19, 2025, subject to the Reporting Person's continuous service on such date."}],"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001415889-24-019904","document":"form4-07232024_120738.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817713/000141588924019904/form4-07232024_120738.xml","form_type":"4"}},{"id":1450523,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-23T00:04:42.000Z","date":"2024-07-19","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in thirty-six equal monthly installments over a three year period, subject to the Reporting Person's continuous service on each such date."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001415889-24-019904","document":"form4-07232024_120738.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817713/000141588924019904/form4-07232024_120738.xml","form_type":"4"}},{"id":1468015,"issuer":{"id":1222,"kind":"organization","name":"Structure Therapeutics Inc.","symbol":"GPCR"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2024-06-27T20:15:08.000Z","date":"2024-06-25","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares (\"ADSs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest in equal monthly installments over the 12 months following June 25, 2024."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer."}],"balance_after":37500,"derivative":{"exercise_price":13.32,"expiration_date":"2034-06-24","underlying":"Ordinary Shares","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001415889-24-018326","document":"form4-06272024_040605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202785/000141588924018326/form4-06272024_040605.xml","form_type":"4"}},{"id":1742064,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-11-14T23:27:14.000Z","date":"2023-11-10","kind":"purchase","planned":false,"acquired":true,"shares":446825,"price":0.2268,"value":101339.91,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $0.2235 to $0.2298. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4."}],"balance_after":563325,"source":{"system":"sec-edgar","filing":"0000905148-23-001449","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202785/000090514823001449/form4.xml","form_type":"4"}},{"id":1809782,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Restricted Stock Units","published_at":"2023-08-11T16:07:10.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":11300,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"When granted, each restricted stock unit (\"RSU\") represented a contingent right to receive one share of the Issuer's Common Stock upon settlement."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"When granted, the RSU award provided for the vesting of restricted stock units for shares of the Issuer's Common Stock contingent upon the achievement of certain performance-based vesting conditions.  Pursuant to the Merger Agreement, at the effective time of the Merger, the performance-based RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"When granted, the RSU award provided for the vesting of restricted stock units for shares of the Issuer's Common Stock contingent upon the achievement of certain performance-based vesting conditions.  Pursuant to the Merger Agreement, at the effective time of the Merger, the performance-based RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F13","text":"When granted, the RSU award provided for the vesting of restricted stock units for shares of the Issuer's Common Stock contingent upon the achievement of certain performance-based vesting conditions.  Pursuant to the Merger Agreement, at the effective time of the Merger, the performance-based RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11300},"source":{"system":"sec-edgar","filing":"0001209191-23-045417","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045417/doc4.xml","form_type":"4"}},{"id":1809781,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Restricted Stock Units","published_at":"2023-08-11T16:07:10.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":64050,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"When granted, each restricted stock unit (\"RSU\") represented a contingent right to receive one share of the Issuer's Common Stock upon settlement."},{"field":"shares","element":"transactionShares","label":"F12","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on January 31, 2024. Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on January 31, 2024. Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on January 31, 2024. Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on January 31, 2024. Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":64050},"source":{"system":"sec-edgar","filing":"0001209191-23-045417","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045417/doc4.xml","form_type":"4"}},{"id":1809780,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Restricted Stock Units","published_at":"2023-08-11T16:07:10.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50001,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"When granted, each restricted stock unit (\"RSU\") represented a contingent right to receive one share of the Issuer's Common Stock upon settlement."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on January 31, 2023. Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on January 31, 2023. Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on January 31, 2023. Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":50001},"source":{"system":"sec-edgar","filing":"0001209191-23-045417","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045417/doc4.xml","form_type":"4"}},{"id":1809779,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Restricted Stock Units","published_at":"2023-08-11T16:07:10.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20248,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"When granted, each restricted stock unit (\"RSU\") represented a contingent right to receive one share of the Issuer's Common Stock upon settlement."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on February 10, 2022.  Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on February 10, 2022.  Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on February 10, 2022.  Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":20248},"source":{"system":"sec-edgar","filing":"0001209191-23-045417","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045417/doc4.xml","form_type":"4"}},{"id":1809778,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Restricted Stock Units","published_at":"2023-08-11T16:07:10.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30797,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"When granted, each restricted stock unit (\"RSU\") represented a contingent right to receive one share of the Issuer's Common Stock upon settlement."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on October 6, 2021. Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on October 6, 2021. Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"When granted, the RSU award provided for ratable vesting in annual installments of one-third beginning on October 6, 2021. Pursuant to the Merger Agreement, at the effective time of the Merger, the RSU award was cancelled and converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such RSU, (i) a cash payment equal to $40.00 (without interest and subject to any applicable tax withholding), and (ii) one CVR."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":30797},"source":{"system":"sec-edgar","filing":"0001209191-23-045417","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045417/doc4.xml","form_type":"4"}},{"id":1809777,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-11T16:07:10.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":255150,"price":14.73,"value":3758359.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This stock option award, which provided for 25% of the award to vest on January 31, 2024 and ratable vesting in 36 additional monthly installments thereafter, became fully vested and was canceled upon effectiveness of the Merger, and was converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such option, (i) a cash payment representing the excess, if any, of the per share merger consideration ($40.00 per share) over the per share exercise price for such option, without interest, and (ii) one CVR, entitling the reporting person to additional cash payments upon the achievement of certain future business milestones pursuant to the Contingent Value Rights Agreement entered into concurrent with the completion of the Merger, in each case subject to applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":25.27,"expiration_date":"2033-01-30","underlying":"Common Stock","underlying_shares":255150},"source":{"system":"sec-edgar","filing":"0001209191-23-045417","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045417/doc4.xml","form_type":"4"}},{"id":1809776,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-11T16:07:10.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":300000,"price":27.1,"value":8130000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This stock option award, which provided for 25% of the award to vest on January 31, 2023 and ratable vesting in 36 additional monthly installments thereafter, became fully vested and was canceled upon effectiveness of the Merger, and was converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such option, (i) a cash payment representing the excess, if any, of the per share merger consideration ($40.00 per share) over the per share exercise price for such option, without interest, and (ii) one CVR, entitling the reporting person to additional cash payments upon the achievement of certain future business milestones pursuant to the Contingent Value Rights Agreement entered into concurrent with the completion of the Merger, in each case subject to applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":12.9,"expiration_date":"2032-01-30","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001209191-23-045417","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045417/doc4.xml","form_type":"4"}},{"id":1809775,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-11T16:07:10.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":178600,"price":24.86,"value":4439996.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This stock option award, which provided for 25% of the award to vest on February 10, 2022 and ratable vesting in 36 additional monthly installments thereafter, became fully vested and was canceled upon effectiveness of the Merger, and was converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such option, (i) a cash payment representing the excess, if any, of the per share merger consideration ($40.00 per share) over the per share exercise price for such option, without interest, and (ii) one CVR, entitling the reporting person to additional cash payments upon the achievement of certain future business milestones pursuant to the Contingent Value Rights Agreement entered into concurrent with the completion of the Merger, in each case subject to applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":15.14,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":178600},"source":{"system":"sec-edgar","filing":"0001209191-23-045417","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045417/doc4.xml","form_type":"4"}},{"id":1809774,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-11T16:07:10.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":271647,"price":25.23,"value":6853653.81,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option award, which provided for 25% of the award to vest on October 6, 2021 and ratable vesting in 36 additional monthly installments thereafter, became fully vested and was canceled upon effectiveness of the Merger, and was converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such option, (i) a cash payment representing the excess, if any, of the per share merger consideration ($40.00 per share) over the per share exercise price for such option, without interest, and (ii) one CVR, entitling the reporting person to additional cash payments upon the achievement of certain future business milestones pursuant to the Contingent Value Rights Agreement entered into concurrent with the completion of the Merger, in each case subject to applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":14.77,"expiration_date":"2030-10-05","underlying":"Common Stock","underlying_shares":271647},"source":{"system":"sec-edgar","filing":"0001209191-23-045417","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045417/doc4.xml","form_type":"4"}},{"id":1809773,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-11T16:07:10.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":313555,"price":39.58,"value":12410506.9,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option award, which provided for 25% of the award to vest on March 6, 2021 and ratable vesting in 36 additional monthly installments thereafter, became fully vested and was canceled upon effectiveness of the Merger, and was converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such option, (i) a cash payment representing the excess, if any, of the per share merger consideration ($40.00 per share) over the per share exercise price for such option, without interest, and (ii) one CVR, entitling the reporting person to additional cash payments upon the achievement of certain future business milestones pursuant to the Contingent Value Rights Agreement entered into concurrent with the completion of the Merger, in each case subject to applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":0.42,"expiration_date":"2030-03-17","underlying":"Common Stock","underlying_shares":313555},"source":{"system":"sec-edgar","filing":"0001209191-23-045417","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045417/doc4.xml","form_type":"4"}},{"id":1809772,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-11T16:07:10.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":353358,"price":39.65,"value":14010644.7,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award, which provided for 25% of the award to vest on April 1, 2020 and ratable vesting in 36 additional monthly installments thereafter, became fully vested and was canceled upon effectiveness of the Merger, and was converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such option, (i) a cash payment representing the excess, if any, of the per share merger consideration ($40.00 per share) over the per share exercise price for such option, without interest, and (ii) one CVR, entitling the reporting person to additional cash payments upon the achievement of certain future business milestones pursuant to the Contingent Value Rights Agreement entered into concurrent with the completion of the Merger, in each case subject to applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":0.35,"expiration_date":"2029-06-05","underlying":"Common Stock","underlying_shares":353358},"source":{"system":"sec-edgar","filing":"0001209191-23-045417","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045417/doc4.xml","form_type":"4"}},{"id":1809771,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-08-11T16:07:10.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":301138,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were disposed of pursuant to the Merger Agreement (defined in the Remarks below).  Upon effectiveness of the Merger (defined in the Remarks below), in exchange for each share of the Issuer's Common Stock, the reporting person received:  (i) $40.00 in cash, without interest and less applicable withholding taxes; and (ii) one contractual contingent value right (each, a \"CVR\"), entitling the reporting person to additional cash payments upon the achievement of certain future business milestones pursuant to the Contingent Value Rights Agreement (the \"Contingent Value Rights Agreement\") entered into concurrent with completion of the Merger."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-045417","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045417/doc4.xml","form_type":"4"}},{"id":1869312,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2023-06-02T23:09:01.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":79500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest on the earlier of May 31, 2024 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service."}],"balance_after":79500,"derivative":{"exercise_price":1.53,"expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":79500},"source":{"system":"sec-edgar","filing":"0001140361-23-028151","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1202785/000114036123028151/form4.xml","form_type":"4"}},{"id":1869311,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-02T23:09:01.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":57000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units shall vest on the earlier of May 31, 2024 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service."}],"balance_after":116500,"source":{"system":"sec-edgar","filing":"0001140361-23-028151","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202785/000114036123028151/form4.xml","form_type":"4"}},{"id":1913297,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-26T17:19:14.000Z","date":"2023-04-24","kind":"exercise","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested as to 25% of the total shares monthly on March 6, 2021, and thereafter vests as to 1/48 of the total shares until fully vested, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":313555,"derivative":{"exercise_price":0.42,"expiration_date":"2030-03-17","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-23-025720","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123025720/doc4.xml","form_type":"4"}},{"id":1913296,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-04-26T17:19:14.000Z","date":"2023-04-24","kind":"sale","planned":false,"acquired":true,"shares":1200,"price":22.2592,"value":26711.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated December 22, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.22 to $22.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":301138,"source":{"system":"sec-edgar","filing":"0001209191-23-025720","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123025720/doc4.xml","form_type":"4"}},{"id":1913295,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-04-26T17:19:14.000Z","date":"2023-04-24","kind":"sale","planned":false,"acquired":false,"shares":23800,"price":21.5768,"value":513527.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated December 22, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.22 to $22.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":302338,"source":{"system":"sec-edgar","filing":"0001209191-23-025720","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123025720/doc4.xml","form_type":"4"}},{"id":1913294,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-04-26T17:19:14.000Z","date":"2023-04-24","kind":"exercise","planned":false,"acquired":true,"shares":25000,"price":0.42,"value":10500.0,"ownership":{"direct":true},"balance_after":326138,"source":{"system":"sec-edgar","filing":"0001209191-23-025720","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123025720/doc4.xml","form_type":"4"}},{"id":2013462,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Restricted Stock Units","published_at":"2023-02-15T16:40:59.000Z","date":"2023-02-10","kind":"exercise","acquired":false,"shares":20248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on February 10, 2022, until fully vested, subject to the reporting person's provision of service to the Issuer on each vesting date."}],"balance_after":20248,"derivative":{"expiration_date":"2024-02-10","underlying":"Common Stock","underlying_shares":20248},"source":{"system":"sec-edgar","filing":"0001209191-23-009773","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123009773/doc4.xml","form_type":"4"}},{"id":2013461,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-02-15T16:40:59.000Z","date":"2023-02-10","kind":"sale","acquired":false,"shares":8097,"price":23.7485,"value":192291.6045,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":301138,"source":{"system":"sec-edgar","filing":"0001209191-23-009773","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123009773/doc4.xml","form_type":"4"}},{"id":2013460,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-02-15T16:40:59.000Z","date":"2023-02-10","kind":"exercise","acquired":true,"shares":20248,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."}],"balance_after":309235,"source":{"system":"sec-edgar","filing":"0001209191-23-009773","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123009773/doc4.xml","form_type":"4"}},{"id":2038430,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Restricted Stock Unit","published_at":"2023-02-01T20:32:14.000Z","date":"2023-01-31","kind":"exercise","acquired":false,"shares":24999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on January 31, 2023, until fully vested, subject to the reporting person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on January 31, 2023, until fully vested, subject to the reporting person's provision of service to the Issuer on each vesting date."}],"balance_after":50001,"derivative":{"underlying":"Common Stock","underlying_shares":24999},"source":{"system":"sec-edgar","filing":"0001209191-23-006054","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123006054/doc4.xml","form_type":"4"}},{"id":2038429,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Restricted Stock Unit","published_at":"2023-02-01T20:32:14.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":64050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on January 31, 2024, until fully vested, subject to the reporting person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on January 31, 2024, until fully vested, subject to the reporting person's provision of service to the Issuer on each vesting date."}],"balance_after":64050,"derivative":{"underlying":"Common Stock","underlying_shares":64050},"source":{"system":"sec-edgar","filing":"0001209191-23-006054","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123006054/doc4.xml","form_type":"4"}},{"id":2038428,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-01T20:32:14.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":255150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option vests as to 25% of the total shares on January 31, 2024, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The stock option vests as to 25% of the total shares on January 31, 2024, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":255150,"derivative":{"exercise_price":25.27,"underlying":"Common Stock","underlying_shares":255150},"source":{"system":"sec-edgar","filing":"0001209191-23-006054","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123006054/doc4.xml","form_type":"4"}},{"id":2038427,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-01T20:32:14.000Z","date":"2023-01-30","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vested as to 25% of the total shares monthly on March 6, 2021, and thereafter vests as to 1/48 of the total shares until fully vested, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":338555,"derivative":{"exercise_price":0.42,"expiration_date":"2030-03-17","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-23-006054","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123006054/doc4.xml","form_type":"4"}},{"id":2038426,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-02-01T20:32:14.000Z","date":"2023-01-31","kind":"sale","acquired":false,"shares":7688,"price":24.6822,"value":189756.7536,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":288987,"source":{"system":"sec-edgar","filing":"0001209191-23-006054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123006054/doc4.xml","form_type":"4"}},{"id":2038425,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-02-01T20:32:14.000Z","date":"2023-01-31","kind":"exercise","acquired":true,"shares":24999,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Restricted stock units (RSUs) convert into common stock on a one-for-one basis."}],"balance_after":296675,"source":{"system":"sec-edgar","filing":"0001209191-23-006054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123006054/doc4.xml","form_type":"4"}},{"id":2038424,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-02-01T20:32:14.000Z","date":"2023-01-30","kind":"sale","acquired":false,"shares":25000,"price":24.5445,"value":613612.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.27 to $24.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":271676,"source":{"system":"sec-edgar","filing":"0001209191-23-006054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123006054/doc4.xml","form_type":"4"}},{"id":2038423,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-02-01T20:32:14.000Z","date":"2023-01-30","kind":"exercise","acquired":true,"shares":25000,"price":0.42,"value":10500.0,"ownership":{"direct":true},"balance_after":296676,"source":{"system":"sec-edgar","filing":"0001209191-23-006054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123006054/doc4.xml","form_type":"4"}},{"id":2085017,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-15T16:27:32.000Z","date":"2022-12-14","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vested as to 25% of the total shares on April 1, 2020, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":353358,"derivative":{"exercise_price":0.35,"expiration_date":"2029-06-05","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-22-061441","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919122061441/doc4.xml","form_type":"4"}},{"id":2085016,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-12-15T16:27:32.000Z","date":"2022-12-14","kind":"exercise","acquired":true,"shares":30000,"price":0.35,"value":10500.0,"ownership":{"direct":true},"balance_after":271676,"source":{"system":"sec-edgar","filing":"0001209191-22-061441","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919122061441/doc4.xml","form_type":"4"}},{"id":2098132,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-02T16:26:37.000Z","date":"2022-12-01","kind":"exercise","acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested as to 25% of the total shares monthly on March 6, 2021, and thereafter vests as to 1/48 of the total shares until fully vested, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":363555,"derivative":{"exercise_price":0.42,"expiration_date":"2030-03-17","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-22-059418","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919122059418/doc4.xml","form_type":"4"}},{"id":2098131,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-12-02T16:26:37.000Z","date":"2022-12-01","kind":"sale","acquired":false,"shares":30000,"price":22.3117,"value":669351.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.08 to $22.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":241676,"source":{"system":"sec-edgar","filing":"0001209191-22-059418","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919122059418/doc4.xml","form_type":"4"}},{"id":2098130,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-12-02T16:26:37.000Z","date":"2022-12-01","kind":"exercise","acquired":true,"shares":60000,"price":0.42,"value":25200.0,"ownership":{"direct":true},"balance_after":271676,"source":{"system":"sec-edgar","filing":"0001209191-22-059418","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919122059418/doc4.xml","form_type":"4"}},{"id":2098129,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-12-02T16:26:37.000Z","date":"2022-12-01","kind":"gift","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":211676,"source":{"system":"sec-edgar","filing":"0001209191-22-059418","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919122059418/doc4.xml","form_type":"4"}},{"id":2139115,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Restricted Stock Units (RSU)","published_at":"2022-10-11T16:33:10.000Z","date":"2022-10-06","kind":"exercise","acquired":false,"shares":30796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on October 6, 2021, until fully vested subject to the reporting person's provision of service to the Issuer on each vesting date."}],"balance_after":30797,"derivative":{"expiration_date":"2030-10-05","underlying":"Common Stock","underlying_shares":30796},"source":{"system":"sec-edgar","filing":"0001209191-22-053303","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919122053303/doc4.xml","form_type":"4"}},{"id":2139114,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-10-11T16:33:10.000Z","date":"2022-10-06","kind":"exercise","acquired":true,"shares":30796,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":236676,"source":{"system":"sec-edgar","filing":"0001209191-22-053303","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919122053303/doc4.xml","form_type":"4"}},{"id":2220984,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2022-06-27T20:48:03.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":31500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest on the earlier of June 23, 2023 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service."}],"balance_after":31500,"derivative":{"exercise_price":7.35,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":31500},"source":{"system":"sec-edgar","filing":"0001140361-22-024160","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1202785/000114036122024160/form4.xml","form_type":"4"}},{"id":2220983,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-06-27T20:48:03.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":20500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units shall vest on the earlier of June 23, 2023 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service."}],"balance_after":59500,"source":{"system":"sec-edgar","filing":"0001140361-22-024160","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202785/000114036122024160/form4.xml","form_type":"4"}},{"id":2253248,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-05-27T18:17:19.000Z","date":"2022-05-25","kind":"purchase","acquired":true,"shares":5000,"price":13.0295,"value":65147.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.80 to $13.2974, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."}],"balance_after":205880,"source":{"system":"sec-edgar","filing":"0001209191-22-032707","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919122032707/doc4.xml","form_type":"4"}},{"id":2397726,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Restricted Stock Units (RSU)","published_at":"2022-02-14T19:54:09.000Z","date":"2022-02-10","kind":"exercise","acquired":false,"shares":20247,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on February 10, 2022, until fully vested, subject to the reporting person's provision of service to the Issuer on each vesting date."}],"balance_after":40496,"derivative":{"expiration_date":"2024-02-10","underlying":"Common Stock","underlying_shares":20247},"source":{"system":"sec-edgar","filing":"0001209191-22-009561","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919122009561/doc4.xml","form_type":"4"}},{"id":2397725,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2022-02-14T19:54:09.000Z","date":"2022-02-10","kind":"exercise","acquired":true,"shares":20247,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":200880,"source":{"system":"sec-edgar","filing":"0001209191-22-009561","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919122009561/doc4.xml","form_type":"4"}},{"id":2416342,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Restricted Stock (RSU)(Common Stock)","published_at":"2022-02-02T17:25:10.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on January 31, 2023, until fully vested, subject to the reporting person's provision of service to the Issuer on each vesting date."}],"balance_after":75000,"derivative":{"expiration_date":"2025-01-31","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-22-006451","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919122006451/doc4.xml","form_type":"4"}},{"id":2416341,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-02T17:25:10.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 25% of the total shares on January 31, 2023, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":300000,"derivative":{"exercise_price":12.9,"expiration_date":"2032-01-30","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001209191-22-006451","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919122006451/doc4.xml","form_type":"4"}},{"id":2458529,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-27T18:24:39.000Z","date":"2021-12-23","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vested as to 25% of the total shares on April 1, 2020, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":383358,"derivative":{"exercise_price":0.35,"expiration_date":"2029-06-05","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-21-071297","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919121071297/doc4.xml","form_type":"4"}},{"id":2458528,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-12-27T18:24:39.000Z","date":"2021-12-23","kind":"exercise","acquired":true,"shares":40000,"price":0.35,"value":14000.0,"ownership":{"direct":true},"balance_after":180633,"source":{"system":"sec-edgar","filing":"0001209191-21-071297","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919121071297/doc4.xml","form_type":"4"}},{"id":2545430,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Restricted Stock Units (RSU)","published_at":"2021-10-08T18:49:50.000Z","date":"2021-10-06","kind":"exercise","acquired":false,"shares":30796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on October 6, 2021, until fully vested subject to the reporting person's provision of service to the Issuer on each vesting date."}],"balance_after":61593,"derivative":{"expiration_date":"2030-10-05","underlying":"Common Stock","underlying_shares":30796},"source":{"system":"sec-edgar","filing":"0001209191-21-060113","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919121060113/doc4.xml","form_type":"4"}},{"id":2545429,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-10-08T18:49:50.000Z","date":"2021-10-06","kind":"exercise","acquired":true,"shares":30796,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":140633,"source":{"system":"sec-edgar","filing":"0001209191-21-060113","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919121060113/doc4.xml","form_type":"4"}},{"id":2561880,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-09-22T19:23:01.000Z","date":"2021-09-20","kind":"purchase","acquired":true,"shares":2000,"price":12,"value":24000.0,"ownership":{"direct":true},"balance_after":109837,"source":{"system":"sec-edgar","filing":"0001209191-21-057315","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919121057315/doc4.xml","form_type":"4"}},{"id":2596063,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-08-19T17:55:10.000Z","date":"2021-08-19","kind":"purchase","acquired":true,"shares":3000,"price":12,"value":36000.0,"ownership":{"direct":true},"balance_after":107837,"source":{"system":"sec-edgar","filing":"0001209191-21-052605","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919121052605/doc4.xml","form_type":"4"}},{"id":2596062,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-08-19T17:55:10.000Z","date":"2021-08-18","kind":"purchase","acquired":true,"shares":7000,"price":11.7376,"value":82163.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.45 to $12.00, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein."}],"balance_after":104837,"source":{"system":"sec-edgar","filing":"0001209191-21-052605","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919121052605/doc4.xml","form_type":"4"}},{"id":2668149,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-15T17:24:44.000Z","date":"2021-06-14","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vested as to 25% of the total shares on April 1, 2020, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":423358,"derivative":{"exercise_price":0.35,"expiration_date":"2029-06-05","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-040659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919121040659/doc4.xml","form_type":"4"}},{"id":2668148,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-06-15T17:24:44.000Z","date":"2021-06-14","kind":"exercise","acquired":true,"shares":20000,"price":0.35,"value":7000.0,"ownership":{"direct":true},"balance_after":97837,"source":{"system":"sec-edgar","filing":"0001209191-21-040659","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919121040659/doc4.xml","form_type":"4"}},{"id":2675333,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2021-06-09T23:07:20.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest on the earlier of June 8, 2022 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service."}],"balance_after":17500,"derivative":{"exercise_price":13.8,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001140361-21-020435","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1202785/000114036121020435/form4.xml","form_type":"4"}},{"id":2675332,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-06-09T23:07:20.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units shall vest on the earlier of June 8, 2022 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service."}],"balance_after":39000,"source":{"system":"sec-edgar","filing":"0001140361-21-020435","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1202785/000114036121020435/form4.xml","form_type":"4"}},{"id":2707772,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-05-18T17:01:37.000Z","date":"2021-05-14","kind":"purchase","acquired":true,"shares":1000,"price":14.44,"value":14440.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Certain of the shares are subject to forfeiture to the Issuer if underlying vesting conditions are not met."}],"balance_after":77837,"source":{"system":"sec-edgar","filing":"0001209191-21-033574","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919121033574/doc4.xml","form_type":"4"}},{"id":2854468,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-18T01:01:21.000Z","date":"2021-02-14","kind":"grant","acquired":true,"shares":3759,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over one year, subject to continued service as a director through such vesting date."}],"balance_after":3759,"derivative":{"exercise_price":66.5,"expiration_date":"2031-02-14","underlying":"Common Stock","underlying_shares":3759},"source":{"system":"sec-edgar","filing":"0001209191-21-011549","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121011549/doc4.xml","form_type":"4"}},{"id":2854467,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-18T01:01:21.000Z","date":"2021-02-14","kind":"grant","acquired":true,"shares":1504,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1504,"source":{"system":"sec-edgar","filing":"0001209191-21-011549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121011549/doc4.xml","form_type":"4"}},{"id":2863100,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Restricted Stock (RSU)(Common Stock)","published_at":"2021-02-12T18:08:49.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":60743,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on February 10, 2022, until fully vested, subject to the reporting person's provision of service to the Issuer on each vesting date."}],"balance_after":60743,"derivative":{"expiration_date":"2024-02-10","underlying":"Common Stock","underlying_shares":60743},"source":{"system":"sec-edgar","filing":"0001209191-21-010383","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919121010383/doc4.xml","form_type":"4"}},{"id":2863099,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-12T18:08:49.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":178600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 25% of the total shares on February 10, 2022, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":178600,"derivative":{"exercise_price":15.14,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":178600},"source":{"system":"sec-edgar","filing":"0001209191-21-010383","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919121010383/doc4.xml","form_type":"4"}},{"id":2915458,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-07T01:00:08.000Z","date":"2021-01-04","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vested with respect to 1/4 of the reporting person's shares on September 28, 2017, with an additional 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":35000,"derivative":{"exercise_price":6.32,"expiration_date":"2026-10-18","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-002379","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121002379/doc4.xml","form_type":"4"}},{"id":2915457,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-07T01:00:08.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":400,"price":59.46,"value":23784.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-002379","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121002379/doc4.xml","form_type":"4"}},{"id":2915456,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-07T01:00:08.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":592,"price":58.67,"value":34732.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $58.395 to 59.27, inclusive."}],"balance_after":400,"source":{"system":"sec-edgar","filing":"0001209191-21-002379","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121002379/doc4.xml","form_type":"4"}},{"id":2915455,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-07T01:00:08.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":5725,"price":57.76,"value":330676.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price.  The shares were sold in multiple transactions ranging from $57.27 to 58.18, inclusive."}],"balance_after":992,"source":{"system":"sec-edgar","filing":"0001209191-21-002379","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121002379/doc4.xml","form_type":"4"}},{"id":2915454,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-07T01:00:08.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":3283,"price":56.1,"value":184176.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price.  The shares were sold in multiple transactions ranging from $55.67 to 56.61, inclusive.   The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":6717,"source":{"system":"sec-edgar","filing":"0001209191-21-002379","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121002379/doc4.xml","form_type":"4"}},{"id":2915453,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-07T01:00:08.000Z","date":"2021-01-04","kind":"exercise","acquired":true,"shares":10000,"price":6.32,"value":63200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2020."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-21-002379","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121002379/doc4.xml","form_type":"4"}},{"id":2934515,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-22T19:47:44.000Z","date":"2020-12-21","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vested as to 25% of the total shares on April 1, 2020, and thereafter vests as to 1/48 of the total shares on a monthly basis until fully vested, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":443358,"derivative":{"exercise_price":0.35,"expiration_date":"2029-06-05","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-064942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919120064942/doc4.xml","form_type":"4"}},{"id":2934514,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2020-12-22T19:47:44.000Z","date":"2020-12-21","kind":"exercise","acquired":true,"shares":20000,"price":0.35,"value":7000.0,"ownership":{"direct":true},"balance_after":76837,"source":{"system":"sec-edgar","filing":"0001209191-20-064942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919120064942/doc4.xml","form_type":"4"}},{"id":2950047,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2020-12-10T17:38:44.000Z","date":"2020-12-09","kind":"purchase","acquired":true,"shares":2000,"price":13.075,"value":26150.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.00 to $13.15, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Certain of the shares are subject to forfeiture to the Issuer if underlying vesting conditions are not met."}],"balance_after":56837,"source":{"system":"sec-edgar","filing":"0001209191-20-062761","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919120062761/doc4.xml","form_type":"4"}},{"id":2950046,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2020-12-10T17:38:44.000Z","date":"2020-12-08","kind":"purchase","acquired":true,"shares":2000,"price":13.2417,"value":26483.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.2333 to $13.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Certain of the shares are subject to forfeiture to the Issuer if underlying vesting conditions are not met."}],"balance_after":54837,"source":{"system":"sec-edgar","filing":"0001209191-20-062761","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919120062761/doc4.xml","form_type":"4"}},{"id":2969750,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2020-11-23T19:26:54.000Z","date":"2020-11-23","kind":"purchase","acquired":true,"shares":929,"price":13.6693,"value":12698.7797,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.60 to $13.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Certain of the shares are subject to forfeiture to the Issuer if underlying vesting conditions are not met."}],"balance_after":52837,"source":{"system":"sec-edgar","filing":"0001209191-20-060088","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919120060088/doc4.xml","form_type":"4"}},{"id":2969749,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2020-11-23T19:26:54.000Z","date":"2020-11-20","kind":"purchase","acquired":true,"shares":571,"price":13.69,"value":7816.99,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Certain of the shares are subject to forfeiture to the Issuer if underlying vesting conditions are not met."}],"balance_after":51908,"source":{"system":"sec-edgar","filing":"0001209191-20-060088","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919120060088/doc4.xml","form_type":"4"}},{"id":2969748,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2020-11-23T19:26:54.000Z","date":"2020-11-19","kind":"purchase","acquired":true,"shares":500,"price":13.5,"value":6750.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Certain of the shares are subject to forfeiture to the Issuer if underlying vesting conditions are not met."}],"balance_after":51337,"source":{"system":"sec-edgar","filing":"0001209191-20-060088","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919120060088/doc4.xml","form_type":"4"}},{"id":2981037,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2020-11-13T18:13:14.000Z","date":"2020-11-11","kind":"purchase","acquired":true,"shares":2500,"price":13.75,"value":34375.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.65 to $13.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Certain of the shares are subject to forfeiture to the Issuer if underlying vesting conditions are not met."}],"balance_after":50837,"source":{"system":"sec-edgar","filing":"0001209191-20-058367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919120058367/doc4.xml","form_type":"4"}},{"id":2981036,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2020-11-13T18:13:14.000Z","date":"2020-11-10","kind":"purchase","acquired":true,"shares":2000,"price":13.86,"value":27720.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.75 to $14.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Certain of the shares are subject to forfeiture to the Issuer if underlying vesting conditions are not met."}],"balance_after":48337,"source":{"system":"sec-edgar","filing":"0001209191-20-058367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919120058367/doc4.xml","form_type":"4"}},{"id":3010792,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Restricted Stock (RSU) (Common Stock)","published_at":"2020-10-07T20:57:21.000Z","date":"2020-10-06","kind":"grant","acquired":true,"shares":92389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each RSU represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on October 6, 2021, until fully vested, subject to the reporting person's provision of service to the Issuer on each vesting date."}],"balance_after":92389,"derivative":{"expiration_date":"2030-10-05","underlying":"Common Stock","underlying_shares":92389},"source":{"system":"sec-edgar","filing":"0001209191-20-054245","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919120054245/doc4.xml","form_type":"4"}},{"id":3010791,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-10-07T20:57:21.000Z","date":"2020-10-06","kind":"grant","acquired":true,"shares":271647,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock option vests as to 25% of the total shares on October 6, 2021, and thereafter vests as to 1/36 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":271647,"derivative":{"exercise_price":14.77,"expiration_date":"2030-10-05","underlying":"Common Stock","underlying_shares":271647},"source":{"system":"sec-edgar","filing":"0001209191-20-054245","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919120054245/doc4.xml","form_type":"4"}},{"id":3010790,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-10-07T20:57:21.000Z","date":"2020-10-05","kind":"grant","acquired":true,"shares":423555,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Received in connection with the Merger in exchange for a stock option to acquire 1,449,600 shares of Private Chinook common stock for $0.12 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vests as to 25% of the total shares on March 6, 2021, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":423555,"derivative":{"exercise_price":0.42,"expiration_date":"2030-03-17","underlying":"Common Stock","underlying_shares":423555},"source":{"system":"sec-edgar","filing":"0001209191-20-054245","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919120054245/doc4.xml","form_type":"4"}},{"id":3010789,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-10-07T20:57:21.000Z","date":"2020-10-05","kind":"grant","acquired":true,"shares":463358,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Received in connection with the merger of Private Chinook into the Issuer (the \"Merger\") in exchange for a stock option to acquire 1,585,822 shares of Private Chinook common stock for $0.10 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested as to 25% of the total shares on April 1, 2020, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":463358,"derivative":{"exercise_price":0.35,"expiration_date":"2029-06-05","underlying":"Common Stock","underlying_shares":463358},"source":{"system":"sec-edgar","filing":"0001209191-20-054245","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919120054245/doc4.xml","form_type":"4"}},{"id":3010788,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2020-10-07T20:57:21.000Z","date":"2020-10-05","kind":"grant","acquired":true,"shares":46337,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Certain of the shares are subject to forfeiture to the Issuer if underlying vesting conditions are not met."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares reported represent the number of shares of Issuer common stock received by the Reporting Person on the Effective Date in connection with the merger of Chinook Therapeutics U.S., Inc. (\"Private Chinook\") into the Issuer."}],"balance_after":46337,"source":{"system":"sec-edgar","filing":"0001209191-20-054245","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919120054245/doc4.xml","form_type":"4"}},{"id":3016188,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-02T23:00:09.000Z","date":"2020-10-01","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested with respect to 1/4 of the reporting person's shares on September 28, 2017, with an additional 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":45000,"derivative":{"exercise_price":6.32,"expiration_date":"2026-10-18","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-053370","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120053370/doc4.xml","form_type":"4"}},{"id":3016187,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-02T23:00:09.000Z","date":"2020-10-01","kind":"sale","acquired":false,"shares":776,"price":49.21,"value":38186.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price.  The shares were sold in multiple transactions ranging from $49.00 to 49.34, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-053370","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120053370/doc4.xml","form_type":"4"}},{"id":3016186,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-02T23:00:09.000Z","date":"2020-10-01","kind":"sale","acquired":false,"shares":9224,"price":48.47,"value":447087.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price.  The shares were sold in multiple transactions ranging from $48.155 to 48.98, inclusive.   The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":776,"source":{"system":"sec-edgar","filing":"0001209191-20-053370","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120053370/doc4.xml","form_type":"4"}},{"id":3016185,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":36738,"kind":"person","name":"DOBMEIER ERIC","position":1,"cik":"0001202785","reported_name":"DOBMEIER ERIC","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-02T23:00:09.000Z","date":"2020-10-01","kind":"exercise","acquired":true,"shares":10000,"price":6.32,"value":63200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2020."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-20-053370","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120053370/doc4.xml","form_type":"4"}}],"next_cursor":"2020-10-02T23:00:09.000000Z,3016185"}